Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10912014 | 1.00 | NPC1 (0.30) | NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL13279599 | 1.00 | NPC1 (0.30) | NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL17304902 | 1.00 | NPC1 (0.30) | NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL10912018 | 1.00 | NPC1 (0.30) | NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL14616164 | 0.91 | — | — | |
| SCHEMBL2755809 | 0.91 | — | — | |
| SCHEMBL10950434 | 0.81 | — | — | |
| SCHEMBL26077107 | 0.81 | — | — | |
| SCHEMBL10950426 | 0.81 | — | — | |
| SCHEMBL3682828 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2697186-B1 | BASE OILS AND THEIR METHODS OF PRODUCTION | AMYRIS INC (US) | 2018-05-23 | — | — | EP | disclosed |
| US-9862906-B2 | Base oils and methods for making the same | Amyris, Inc. (US) | 2018-01-09 | — | — | US | disclosed |
| US-20140221258-A1 | BASE OILS AND METHODS FOR MAKING THE SAME | Amyris, Inc. (US) | 2014-08-07 | — | — | US | disclosed |
| EP-2697186-A1 | BASE OILS AND METHODS FOR MAKING THE SAME | Amyris, Inc. (US) | 2014-02-19 | — | — | EP | disclosed |
| WO-2012141784-A1 | BASE OILS AND METHODS FOR MAKING THE SAME | Amyris, Inc. (US) | 2012-10-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140221258-A1 | BASE OILS AND METHODS FOR MAKING THE SAME | OSBP, OSBPL8, FDFT1 | NPC1 259/4885RAB9A 4426/4885SMN1; SMN2 2519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.